If you enjoyed this talk, consider joining the Molecular Modeling and Drug Discovery (M2D2) talks live: https://valence-discovery.github.io/M...

Also consider joining the M2D2 Slack: https://join.slack.com/t/m2d2group/sh...

Abstract: Combining drugs opens new possibilities for tailoring therapies to a given disease and targeting several biological pathways at the same time. However the number of possible drug combinations is huge, and only a tiny portion of this space can be explored in a reasonable amount of time. One could either narrowly focus on experimenting with a very restricted number of well-chosen drugs, based on pre-existing biological knowledge, or broaden the scope by exploring uncharted territories with the risk of very low time and cost efficiency. 

Speaker: Paul Bertin - https://bertinus.github.io/ 

Twitter Prudencio: https://twitter.com/tossouprudencio 

Twitter Therence: https://twitter.com/Therence_mtl 

Twitter Cas: https://twitter.com/cas_wognum 

Twitter Valence Discovery: https://twitter.com/valence_ai